Concepedia

Russell P. Rother

RP

53

Publications

8.7K

Citations

33

H-Index

1991

Active since

Affiliations

Alexion Pharmaceuticals (United States)(Current)

Alexion Pharma (Switzerland)

National Heart Lung and Blood Institute

St James's University Hospital

Saarland University

Russell P. Rother is an author at Alexion Pharmaceuticals (United States) specializing in medicine, immunology, and immunotherapy.

Top concepts

Publications per year

1991–2016

53

Publications

53

The Complement Inhibitor Eculizumab in Paroxysmal Nocturnal Hemoglobinuria

Peter Hillmen, Neal S. Young, Jörg Schubert et al. · New England Journal of Medicine · 2006 · 1.2K citations · Full text

Crizanlizumab for the Prevention of Pain Crises in Sickle Cell Disease

Kenneth I. Ataga, Abdullah Kutlar, Julie Kanter et al. · New England Journal of Medicine · 2016 · 837 citations · Full text

Discovery and development of the complement inhibitor eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria

Russell P. Rother, Scott A. Rollins, Christopher F. Mojcik et al. · Nature Biotechnology · 2007 · 752 citations

, , +5

Multicenter phase 3 study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuria

Robert A. Brodsky, Neal S. Young, Elisabetta Antonioli et al. · Blood · 2007 · 640 citations

Effect of Eculizumab on Hemolysis and Transfusion Requirements in Patients with Paroxysmal Nocturnal Hemoglobinuria

Peter Hillmen, Claire Hall, Judith Marsh et al. · New England Journal of Medicine · 2004 · 631 citations · Full text

Rows per page

1–5 of 53